Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Cajal Neuroscience Inc.

Headquarters: Seattle, WA, United States of America
Year Founded: 2020
Status: Private
BioCentury | Jan 14, 2023
Discovery & Translation

Ubiquitin-regulation for tauopathies; plus Regeneron’s IL2RG mAb for T cell-driven disease and more

BioCentury’s round-up of translational news
BioCentury | Jan 10, 2023
Emerging Company Profile

Cajal: integrating anatomy and genetics to discover CNS targets

Seattle-based company is pairing genetics with the modern neuroanatomy tools to discover targets for Parkinson’s and Alzheimer’s 
BioCentury | Nov 30, 2022
Deals

Nov. 29 Quick Takes: Horizon names three possible buyers, discloses early M&A talks

Plus: TCG, Lux lead $96M A round for Cajal and updates from Sana, X4, Roche, Ribon and more
Items per page:
1 - 3 of 3